$5.14
0.142.80%
At Close: -
$5.00
-0.14-2.72%
After Hours: Jul 2, 4:10 PM EDT
15 minutes delayed
Verve Therapeutics
VERVNASDAQ
Verve Therapeutics (VERV) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerve Therapeutics (NASDAQ:VERV) 주식 시세 및 뉴스 요약
Verve Therapeutics 주식 (NASDAQ: VERV) 주가, 뉴스, 차트, 주식 조사, 프로필.
| Open | $5.00 |
| Close | $5.14 |
| Volume / Avg. | 715.61K / 1.53M |
| Day Range | 5.00 - 5.37 |
| 52 Wk Range | 4.59 - 21.04 |
| Market Cap | $419.83M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 25.13% |
| Days to Cover | 15.88 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Verve Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verve Therapeutics (VERV) stock?
You can purchase shares of Verve Therapeutics (NASDAQ:VERV) through any online brokerage.
Who are Verve Therapeutics (VERV) competitors?
Other companies in Verve Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
What is the target price for Verve Therapeutics (VERV) stock?
There is no analysis for Verve Therapeutics.
What is the forecast for Verve Therapeutics (VERV) stock?
Verve Therapeutics has a consensus price target of $40.62.
Current stock price for Verve Therapeutics (VERV)?
The stock price for Verve Therapeutics (NASDAQ: VERV) is $5 last updated July 2, 2024 at 4:10 PM EDT.
Does Verve Therapeutics (VERV) pay a dividend?
There are no upcoming dividends for Verve Therapeutics.
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
Verve Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Verve Therapeutics (VERV) going to split?
There is no upcoming split for Verve Therapeutics.
What sector and industry does Verve Therapeutics (VERV) operate in?
Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.